The NIH has awarded OMRF scientist Matlock Jeffries $874,000 to launch an innovative study of the origin and progression of OA.
Last week, the drug company AstraZeneca halted its SARS-CoV-2 vaccine trial. What happened?
Cancer often returns after successful therapy, but why?
New findings could help scientists develop treatments for the condition known as ITP.
New research will help physicians better identify blood relatives of lupus patients at risk for developing the disease.
Abnormal numbers of chromosomes—known as aneuploidy—are a common cause of genetic disorders and birth defects.